Literature DB >> 24316956

Lymph node status does not predict local recurrence in the total mesorectal excision era.

Manish Chand1, Brendan J Moran, Robert G Jones, Richard J Heald, Gina Brown.   

Abstract

Mesh:

Year:  2014        PMID: 24316956     DOI: 10.1097/DCR.0000000000000001

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  5 in total

1.  Association of certification, improved quality and better oncological outcomes for rectal cancer in a specialized colorectal unit.

Authors:  Annika Jacob; Wolfgang Albert; Thomas Jackisch; Christiane Jakob; Anja Sims; Helmut Witzigmann; Sören Torge Mees; Sigmar Stelzner
Journal:  Int J Colorectal Dis       Date:  2020-11-09       Impact factor: 2.571

2.  Clinically Node Negative, Pathologically Node Positive Rectal Cancer Patients Who Did Not Receive Neoadjuvant Therapy.

Authors:  Nouf Akeel; Nan Lan; Luca Stocchi; Meagan M Costedio; David W Dietz; Emre Gorgun; Matthew F Kalady; Georgios Karagkounis; Hermann Kessler; Feza H Remzi
Journal:  J Gastrointest Surg       Date:  2016-10-27       Impact factor: 3.452

3.  Transanal total mesorectal excision in the prone jackknife position without being conscious of the size of prostatic enlargement for lower rectal cancer.

Authors:  Dai Uematsu; Gaku Akiyama; Takeiko Sugihara; Akiko Magishi; Minoru Imai; Kojiro Ono
Journal:  Int Cancer Conf J       Date:  2020-04-20

Review 4.  The multidisciplinary management of rectal cancer.

Authors:  Deborah S Keller; Mariana Berho; Rodrigo O Perez; Steven D Wexner; Manish Chand
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-03-12       Impact factor: 46.802

5.  Long-term outcomes of surgery alone versus surgery following preoperative chemoradiotherapy for early T3 rectal cancer: A propensity score analysis.

Authors:  Seung Hyun Cho; Gyu-Seog Choi; Gab Chul Kim; An Na Seo; Hye Jung Kim; Won Hwa Kim; Kyung-Min Shin; So Mi Lee; Hunkyu Ryeom; See Hyung Kim
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.